Nicotinamide adenine dinucleotide β more commonly referenced as NAD+ β is a coenzyme found in every living cell and has become one of the most actively researched molecules in longevity and metabolic biology over the past two decades. A 2026 PRISMA-guided systematic review in ScienceDirect noted that NAD+ research has expanded dramatically, with studies spanning preclinical models through human interventional trials examining its role across a wide range of biological processes. This post provides a research-focused overview of what the peer-reviewed literature has explored regarding NAD+ and its decline with age.
NAD+ is a dinucleotide coenzyme β a molecule that assists enzymes in carrying out biochemical reactions β present in all living organisms. It exists in two primary forms: the oxidized form (NAD+) and its reduced counterpart (NADH), with the ratio between these two forms playing a critical regulatory role in cellular metabolism.
Its phosphorylated counterpart, NADP+/NADPH, is involved in separate but related biosynthetic pathways including fatty acid synthesis, steroidogenesis, and reactive oxygen species (ROS) homeostasis.
A comprehensive review published in Endocrine Reviews (Bhasin et al., 2023 β PMID: 37364580) characterized NAD+ as having an “expansive role in cellular energy generation, redox reactions, and as a substrate or cosubstrate in signalling pathways that regulate health span and ageing,” representing one of the most thorough appraisals of NAD+ biology in the current literature.
One of the most consistent findings in NAD+ research is the age-associated decline in cellular NAD+ levels. A 2025 review published in Nature Aging β co-authored by more than 25 scientists from the University of Oslo, Akershus University Hospital, and international collaborators β characterized NAD+ as a central regulator of cellular energy, DNA repair, and cellular homeostasis, noting that its decline with age represents one of the most reproducible molecular signatures in aging biology.
A separate 2025 ChemRxiv review synthesizing more than 60 peer-reviewed studies described the age-related drop in NAD+ as driving “metabolic slowdown, mitochondrial dysfunction, DNA-repair deficits, chronic inflammation, and stem-cell fatigue” β a characterization now broadly reflected across the longevity research literature.
The Bhasin et al. Endocrine Reviews comprehensive review noted that “NAD+ levels decrease throughout life” and that “age-related decline in NAD+ bioavailability has been postulated to be a contributor to many age-related diseases” β framing the decline not as an incidental finding but as a mechanistically significant feature of the aging process.
NAD+’s most fundamental role in research is its function as an electron carrier in cellular energy metabolism. In the process of cellular respiration, NAD+ accepts electrons during glycolysis and the citric acid cycle, becoming NADH. This NADH then delivers electrons to the mitochondrial electron transport chain, where the energy released drives the synthesis of adenosine triphosphate (ATP) β the primary energy currency of the cell.
Research has established that NAD+/NADH ratios are tightly regulated and serve as critical metabolic sensors. When NAD+ levels decline, the efficiency of ATP production is compromised β a finding that has informed research into the relationship between NAD+ status and mitochondrial function.
A PMC review examining NAD+ metabolism and mitochondrial function noted that “declining levels of NAD+ are associated with general aging and chronic disorders, including cognitive decline, sarcopenia, and metabolic diseases” and that these conditions “are typified by loss of mitochondrial health through dysfunction of homeostatic components such as mitophagy, unfolded protein response, and the antioxidant system.”
One of the most extensively studied mechanisms through which NAD+ influences cellular biology is via its role as a required substrate for sirtuin (SIRT) enzymes β a family of NAD+-dependent deacetylases with roles in gene expression regulation, DNA repair, and metabolic homeostasis.
Seven sirtuins (SIRT1-7) have been identified in mammals, each with distinct subcellular localizations and substrate specificities. SIRT1 has been most extensively studied in the context of metabolic regulation and has been linked to the regulation of PGC-1Ξ± β a key transcriptional coactivator of mitochondrial biogenesis. SIRT3 is localized to the mitochondria and has been studied in connection with mitochondrial protein deacetylation and oxidative phosphorylation efficiency.
Because sirtuins require NAD+ as a cosubstrate β consuming NAD+ as they carry out deacetylation reactions β the availability of NAD+ directly limits sirtuin activity. Research has explored this dependency as a potential mechanism linking NAD+ decline with the attenuation of sirtuin-mediated protective processes observed in ageing models.
Poly(ADP-ribose) polymerases (PARPs) represent another major NAD+-consuming enzyme family studied in the context of NAD+ biology. PARPs are activated in response to DNA strand breaks and use NAD+ to synthesize poly(ADP-ribose) chains involved in DNA damage signaling and repair coordination.
Research has explored a potential feedback loop in which accumulated DNA damage in aging cells activates PARPs, consuming NAD+ at elevated rates β potentially contributing to the age-related decline in NAD+ availability and creating a cycle where reduced NAD+ limits the efficiency of the very repair processes that depend on it.
Beyond sirtuins and PARPs, research has examined CD38 β an NAD+-consuming enzyme expressed on immune cells and other tissues β as a potential contributor to age-related NAD+ decline. Studies have documented increased CD38 expression and activity with aging, leading to increased NAD+ consumption. Preclinical research exploring CD38 inhibition has shown partial restoration of NAD+ levels in aged animal models, supporting CD38’s role as a significant driver of the age-associated NAD+ deficit.
NAD+ is synthesized through multiple pathways, the most studied of which involve dietary precursors. The salvage pathway β the primary route for NAD+ recycling in most mammalian cells β converts nicotinamide (Nam) back to NAD+ via the rate-limiting enzyme NAMPT (nicotinamide phosphoribosyltransferase). Research has examined NAMPT expression and activity as a potential bottleneck in NAD+ maintenance, particularly in aging contexts where NAMPT expression has been shown to decline.
The Preiss-Handler pathway converts dietary niacin (nicotinic acid) to NAD+ via NaMN and NaAD intermediates. More recently, research has examined nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) as NAD+ precursors that enter the salvage pathway at different points, with several human intervention studies examining their effects on tissue NAD+ levels.
The relationship between NAD+ and mitochondrial health has become a central theme in longevity research. NAD+ is required not only for mitochondrial energy production but also for the activity of SIRT3 β the primary mitochondrial sirtuin β and for the function of SIRT1-mediated mitochondrial biogenesis signaling through PGC-1Ξ±.
Research examining NAD+ restoration in aged animal models has documented improvements in mitochondrial morphology, respiratory capacity, and markers of mitochondrial biogenesis β findings that have motivated ongoing human research into NAD+ augmentation strategies.
| Research Area | Key Mechanism |
| Energy metabolism | Electron carrier in glycolysis and TCA cycle; ATP production |
| Sirtuin signaling | Required NAD+ cosubstrate for SIRT1-7 deacetylase activity |
| DNA repair | PARP enzyme substrate for poly(ADP-ribose) synthesis |
| Mitochondrial function | SIRT3, PGC-1Ξ±, mitochondrial biogenesis |
| Age-related decline | CD38 upregulation, NAMPT decline, increased consumption |
| Redox homeostasis | NAD+/NADH ratio as metabolic sensor |
| Biosynthesis research | Salvage pathway, NR/NMN precursor studies |
NAD+ is available in our Longevity Collection for research and analytical use only.
All products sold by Forward Peptides are intended strictly for research and analytical use only. Not for human or animal consumption. For laboratory use only. This content is provided for informational and research reference purposes and does not constitute medical advice.
Discount Applied Successfully!
Your savings have been added to the cart.
